Nigerian government urged to establish fund to stimulate pharma manufacturing

Muhammadu Buhari
Nigerian president Muhammadu Buhari.

Members of the Pharmaceutical Society of Nigeria (PSN) are urging government officials to establish a development fund to stimulate and expand the country’s pharma manufacturing sector.

In a recent presentation, the group urged President Muhammadu Buhari to follow the lead in Ghana and other West African countries where pharmaceutical manufacturing development funds have been set up, The National Mirror of Nigeria reported.

Ahmed Yakasai, president of PSN, said that establishing such a fund with respect to accessing FOREX (foreign exchange) would allow manufacturers to quickly stock pharmaceutical raw materials when they run low, which would guarantee an uninterrupted supply of medicines to the Nigerian people. Additionally, he urged lawmakers to extend a 0% common external tariff to raw and packaging materials that currently have duties that range from 5% to 20%.


Simplify and Accelerate Drug R&D With the MarkLogic Data Hub Service for Pharma R&D

Researchers are often unable to access the information they need. And, even when data does get consolidated, researchers find it difficult to sift through it all and make sense of it in order to confidently draw the right conclusions and share the right results. Discover how to quickly and easily find, synthesize, and share information—accelerating and improving R&D.

“Our industry has the potential to contribute over a million jobs to the Nigerian economy,” PSN leaders told The National Mirror. “A majority of [World Health Organization]-certified pharmaceutical companies in Africa are from Nigeria. Through exportation, the Nigerian pharmaceutical sector can therefore become a major FOREX earner for the country.”

The group also called for changes in qualifications to become the Director General of the National Agency for Food and Drug Administration and Control that require candidates to have a good knowledge of pharmacy, food and drugs.

- check out the National Mirror story
- read more here


Suggested Articles

Three Samsung execs face up to two years in jail for their roles in destroying data and documents at under-fire affiliate Samsung BioLogics.

The FDA has slapped a U.S. drug repackager, saying in a warning letter that its storage processes and equipment cleaning are not up to expectations.

Higher operating costs were behind a 17% slide in pretax profits last year at Allergan’s Mayo, Ireland, facility that produces Botox.